Characterization and outcomes of cats with cardiomyopathy undergoing subcutaneous ureteral bypass device placement.

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Journal of veterinary internal medicine in 2026 evaluated characterization and outcomes of cats with cardiomyopathy undergoing subcutaneous ureteral bypass device placement..

Key Findings

Limited data exist on the characterization and outcomes of cats with cardiomyopathy and benign ureteral obstruction treated by subcutaneous ureteral bypass (SUB) placement. Characterize cardiomyopathies, assess perioperative and long-term outcomes, and determine if an association exists between left atrial size and fluid overload (FO) or survival. Ninety-four cats presented for SUB placement between 2010 and 2022 at the Veterinary Teaching Hospital of the University of Montreal. Retrospective review of medical records including physical examination, serum creatinine concentration, echocardiography, and outcome. Cats were grouped as:...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for feline patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.